Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Relapse Management”

195 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 195 results

Early research (Phase 1)Study completedNCT04163107
What this trial is testing

Combined Carfilzomib and Hydroxychloroquine in Patients With Relapsed/Refractory Multiple Myeloma

Who this might be right for
Multiple Myeloma
Norwegian University of Science and Technology 19
Early research (Phase 1)Ended earlyNCT05904236
What this trial is testing

Safety and Tolerability of Intravenous Administration of ICVB-1042

Who this might be right for
Patients With Advanced Solid Tumors
IconOVir Bio 17
Testing effectiveness (Phase 2)Enrolling By InvitationNCT06223074
What this trial is testing

Improving the Treatment of Acute Relapses in Multiple Sclerosis Through Intranasal Methylprednisolone Administration

Who this might be right for
Multiple Sclerosis Relapsing RemittingTreatment
Universidad Nacional Autonoma de Mexico 80
Testing effectiveness (Phase 2)Study completedNCT03892421
What this trial is testing

Outpatient Administration of R-DHAP in Relapsed/Refractory Non-Hodgkin Lymphoma

Who this might be right for
Relapsed Non Hodgkin LymphomaRefractory Non-Hodgkin Lymphoma
La Raza Medical Center 22
Testing effectiveness (Phase 2)Study completedNCT00723346
What this trial is testing

Administration of Allogenic Red Blood Cells Loaded L-asparaginase in Cases of Relapse of Acute Lymphoblastic Leukaemia

Who this might be right for
Acute Lymphoblastic Leukemia
ERYtech Pharma 25
Testing effectiveness (Phase 2)Active Not RecruitingNCT02690545
What this trial is testing

Study of CD30 CAR for Relapsed/Refractory CD30+ HL and CD30+ NHL

Who this might be right for
LymphomaLymphoma, Non-HodgkinImmune System Diseases+5 more
UNC Lineberger Comprehensive Cancer Center 38
Testing effectiveness (Phase 2)Study completedNCT00787761
What this trial is testing

Early Administration of ATG Followed by Cyclophosphamide, Busulfan and Fludarabine Before a Donor Stem Cell Transplant in Patients With Hematological Cancer

Who this might be right for
Myeloproliferative DisordersKidney CancerLeukemia+4 more
Northside Hospital, Inc. 24
Testing effectiveness (Phase 2)Looking for participantsNCT05674175
What this trial is testing

Co-administration of CART22-65s and huCART19 for B-ALL

Who this might be right for
B-cell Acute Lymphoblastic LeukemiaB Lineage Lymphoblastic Lymphoma
Stephan Grupp MD PhD 93
Testing effectiveness (Phase 2)UnknownNCT04867928
What this trial is testing

Venetoclax and Azacitidine for the Management of Molecular Relapse/Progression in Adult NPM1-mutated Acute Myeloid Leukemia

Who this might be right for
Acute Myeloid LeukemiaAcute Myeloid Leukemia, in RelapseNPM1 Mutation
Gruppo Italiano Malattie EMatologiche dell'Adulto 35
Post-approval studies (Phase 4)Study completedNCT01585298
What this trial is testing

STudy to vAlidate telemetRic ECG Systems for firsT Dose Administration of Fingolimod (START)

Who this might be right for
Multiple Sclerosis
Novartis Pharmaceuticals 6,998
Not applicableNot Yet RecruitingNCT07713511
What this trial is testing

INfections in Patients Treated With CAR-T

Who this might be right for
Relapsed Multiple MyelomaRefractory Multiple MyelomaB-Cell Non-Hodgkin Lymphoma+2 more
IRCCS Azienda Ospedaliero-Universitaria di Bologna 290
Early research (Phase 1)Study completedNCT00837785
What this trial is testing

A 24-Hour Pharmacokinetic Determination of BG00012 After Single-Day Oral Administration in Subjects With MS

Who this might be right for
Relapsing Remitting Multiple Sclerosis
Biogen 48
Early research (Phase 1)Ended earlyNCT00082225
What this trial is testing

LMP2a-Specific Cytotoxic T-Lymphocytes, Lymphoma (ACDAL)

Who this might be right for
Lymphoma
Baylor College of Medicine 4
Testing effectiveness (Phase 2)Study completedNCT03754634
What this trial is testing

A Prospective, Open, Multicenter Clinical Trial of Eltrombopag Combined With Diacerein in Eltrombopag-inefficient or Relapsed ITP

Who this might be right for
Thrombocytopenia
Shandong University 30
Testing effectiveness (Phase 2)UnknownNCT06434818
What this trial is testing

Enhanced Digital-Chemosensory-Based Olfactory Training for Remote Management of Substance Use Disorders

Who this might be right for
Substance Use DisordersOpioid Use DisorderAlcohol Use Disorder+2 more
Evon Medics LLC 300
Early research (Phase 1)Ended earlyNCT00383097
What this trial is testing

Lmp1 and Lmp2 Specific CTLs Following Cd45 Antibody for Relapsed Ebv-Positive Hodgkin's Or Non-Hodgkin's Lymphoma

Who this might be right for
Hodgkins LymphomaNon-Hodgkin Lymphoma
Baylor College of Medicine 6
Large-scale testing (Phase 3)UnknownNCT01316744
What this trial is testing

Ketamine Hydrochloride and Best Pain Management in Treating Cancer Patients With Neuropathic Pain

Who this might be right for
Cancer
University of Glasgow 214
Not applicableNot Yet RecruitingNCT07327944
What this trial is testing

Relapse Management Group Psychoeducation Program

Who this might be right for
Relapse Management
Ankara Etlik City Hospital 60
Large-scale testing (Phase 3)Not Yet RecruitingNCT07503340
What this trial is testing

Evaluate Pharmacokinetics, Safety, Tolerability, Immunogenicity and Pharmacodynamic Effects of Subcutaneous Ocrelizumab Administration in Children and Adolescents With Relapsing-remitting Multiple Sclerosis (RRMS)

Who this might be right for
Relapsing-remitting Multiple Sclerosis
Hoffmann-La Roche 25
Post-approval studies (Phase 4)Study completedNCT00381355
What this trial is testing

RCT of a Written Action Plan vs. Usual Care in Children With Acute Asthma

Who this might be right for
Asthma
McGill University Health Centre/Research Institute of the McGill University Health Centre 218
Next Page